In non-COVID-19 patients with GBS, P2 and—to a lesser extent—P0 were the main self-antigens targeted during the acute phase of the disease, whereas the autoreactive CD4+ T response was significantly increased against all three PNS-myelin antigens during the recovery phase (Fig. 1c). This evidence concerns the gene CD4 and Guillain-Barre syndrome.